Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Singapore
Pharma
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Merck licensed a bispecific from Curon. Legend is taking a close look at its business. The FDA flagged missing adverse events in an Amgen filing.
Angus Liu
Aug 16, 2024 8:59am
China deals, Enhertu, Samsung Bio—Fierce Pharma Asia
Jul 26, 2024 1:45am
In Singapore, Pfizer cuts ribbon on $743M extension of API plant
Jul 23, 2024 9:43am
AstraZeneca, Hengrui, Takeda—Fierce Pharma Asia
May 24, 2024 8:31am
AZ plots $1.5B antibody-drug conjugate plant in Asia
May 20, 2024 9:45am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am